A recombinant platform for flavivirus vaccines and diagnostics using chimeras of a new insect-specific virus

Flaviviruses such as dengue, yellow fever, Zika, West Nile, and Japanese encephalitis virus present substantial global health burdens. New vaccines are being sought to address safety and manufacturing issues associated with current live attenuated vaccines. Here, we describe a new insect-specific fl...

Full description

Saved in:
Bibliographic Details
Published inScience translational medicine Vol. 11; no. 522
Main Authors Hobson-Peters, Jody, Harrison, Jessica J, Watterson, Daniel, Hazlewood, Jessamine E, Vet, Laura J, Newton, Natalee D, Warrilow, David, Colmant, Agathe M G, Taylor, Carmel, Huang, Bixing, Piyasena, Thisun B H, Chow, Weng Kong, Setoh, Yin Xiang, Tang, Bing, Nakayama, Eri, Yan, Kexin, Amarilla, Alberto A, Wheatley, Sarah, Moore, Peter R, Finger, Mitchell, Kurucz, Nina, Modhiran, Naphak, Young, Paul R, Khromykh, Alexander A, Bielefeldt-Ohmann, Helle, Suhrbier, Andreas, Hall, Roy A
Format Journal Article
LanguageEnglish
Published United States 11.12.2019
Online AccessGet more information

Cover

Loading…
Abstract Flaviviruses such as dengue, yellow fever, Zika, West Nile, and Japanese encephalitis virus present substantial global health burdens. New vaccines are being sought to address safety and manufacturing issues associated with current live attenuated vaccines. Here, we describe a new insect-specific flavivirus, Binjari virus, which was found to be remarkably tolerant for exchange of its structural protein genes (prME) with those of the aforementioned pathogenic vertebrate-infecting flaviviruses (VIFs). Chimeric BinJ/VIF-prME viruses remained replication defective in vertebrate cells but replicated with high efficiency in mosquito cells. Cryo-electron microscopy and monoclonal antibody binding studies illustrated that the chimeric BinJ/VIF-prME virus particles were structurally and immunologically similar to their parental VIFs. Pilot manufacturing in C6/36 cells suggests that high yields can be reached up to 10 cell culture infectious dose/ml or ≈7 mg/liter. BinJ/VIF-prME viruses showed utility in diagnostic (microsphere immunoassays and ELISAs using panels of human and equine sera) and vaccine applications (illustrating protection against Zika virus challenge in murine IFNAR mouse models). BinJ/VIF-prME viruses thus represent a versatile, noninfectious (for vertebrate cells), high-yield technology for generating chimeric flavivirus particles with low biocontainment requirements.
AbstractList Flaviviruses such as dengue, yellow fever, Zika, West Nile, and Japanese encephalitis virus present substantial global health burdens. New vaccines are being sought to address safety and manufacturing issues associated with current live attenuated vaccines. Here, we describe a new insect-specific flavivirus, Binjari virus, which was found to be remarkably tolerant for exchange of its structural protein genes (prME) with those of the aforementioned pathogenic vertebrate-infecting flaviviruses (VIFs). Chimeric BinJ/VIF-prME viruses remained replication defective in vertebrate cells but replicated with high efficiency in mosquito cells. Cryo-electron microscopy and monoclonal antibody binding studies illustrated that the chimeric BinJ/VIF-prME virus particles were structurally and immunologically similar to their parental VIFs. Pilot manufacturing in C6/36 cells suggests that high yields can be reached up to 10 cell culture infectious dose/ml or ≈7 mg/liter. BinJ/VIF-prME viruses showed utility in diagnostic (microsphere immunoassays and ELISAs using panels of human and equine sera) and vaccine applications (illustrating protection against Zika virus challenge in murine IFNAR mouse models). BinJ/VIF-prME viruses thus represent a versatile, noninfectious (for vertebrate cells), high-yield technology for generating chimeric flavivirus particles with low biocontainment requirements.
Author Warrilow, David
Chow, Weng Kong
Suhrbier, Andreas
Hazlewood, Jessamine E
Bielefeldt-Ohmann, Helle
Harrison, Jessica J
Watterson, Daniel
Colmant, Agathe M G
Hobson-Peters, Jody
Kurucz, Nina
Setoh, Yin Xiang
Hall, Roy A
Newton, Natalee D
Piyasena, Thisun B H
Finger, Mitchell
Taylor, Carmel
Yan, Kexin
Vet, Laura J
Khromykh, Alexander A
Moore, Peter R
Modhiran, Naphak
Huang, Bixing
Tang, Bing
Nakayama, Eri
Amarilla, Alberto A
Young, Paul R
Wheatley, Sarah
Author_xml – sequence: 1
  givenname: Jody
  orcidid: 0000-0003-0139-9829
  surname: Hobson-Peters
  fullname: Hobson-Peters, Jody
  email: roy.hall@uq.edu.au, j.peters2@uq.edu.au
  organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia. roy.hall@uq.edu.au j.peters2@uq.edu.au
– sequence: 2
  givenname: Jessica J
  orcidid: 0000-0002-3577-9910
  surname: Harrison
  fullname: Harrison, Jessica J
  organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia
– sequence: 3
  givenname: Daniel
  orcidid: 0000-0001-5957-2853
  surname: Watterson
  fullname: Watterson, Daniel
  organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia
– sequence: 4
  givenname: Jessamine E
  orcidid: 0000-0001-6104-4531
  surname: Hazlewood
  fullname: Hazlewood, Jessamine E
  organization: Inflammation Biology Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia
– sequence: 5
  givenname: Laura J
  orcidid: 0000-0001-7587-2936
  surname: Vet
  fullname: Vet, Laura J
  organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia
– sequence: 6
  givenname: Natalee D
  orcidid: 0000-0002-5617-8639
  surname: Newton
  fullname: Newton, Natalee D
  organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia
– sequence: 7
  givenname: David
  orcidid: 0000-0002-3221-7605
  surname: Warrilow
  fullname: Warrilow, David
  organization: Public Health Virology Laboratory, Department of Health, Queensland Government, PO Box 594, Archerfield, Queensland, Australia
– sequence: 8
  givenname: Agathe M G
  orcidid: 0000-0002-2004-4073
  surname: Colmant
  fullname: Colmant, Agathe M G
  organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia
– sequence: 9
  givenname: Carmel
  surname: Taylor
  fullname: Taylor, Carmel
  organization: Public Health Virology Laboratory, Department of Health, Queensland Government, PO Box 594, Archerfield, Queensland, Australia
– sequence: 10
  givenname: Bixing
  orcidid: 0000-0002-7025-2292
  surname: Huang
  fullname: Huang, Bixing
  organization: Public Health Virology Laboratory, Department of Health, Queensland Government, PO Box 594, Archerfield, Queensland, Australia
– sequence: 11
  givenname: Thisun B H
  orcidid: 0000-0002-1657-8558
  surname: Piyasena
  fullname: Piyasena, Thisun B H
  organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia
– sequence: 12
  givenname: Weng Kong
  orcidid: 0000-0003-3609-2499
  surname: Chow
  fullname: Chow, Weng Kong
  organization: Australian Defence Force Malaria and Infectious Disease Institute, Gallipoli Barracks, Queensland, Australia
– sequence: 13
  givenname: Yin Xiang
  orcidid: 0000-0002-1683-3555
  surname: Setoh
  fullname: Setoh, Yin Xiang
  organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia
– sequence: 14
  givenname: Bing
  orcidid: 0000-0003-0281-2160
  surname: Tang
  fullname: Tang, Bing
  organization: Inflammation Biology Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia
– sequence: 15
  givenname: Eri
  orcidid: 0000-0002-0826-3513
  surname: Nakayama
  fullname: Nakayama, Eri
  organization: Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan
– sequence: 16
  givenname: Kexin
  orcidid: 0000-0003-2203-217X
  surname: Yan
  fullname: Yan, Kexin
  organization: Inflammation Biology Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia
– sequence: 17
  givenname: Alberto A
  orcidid: 0000-0002-6640-3377
  surname: Amarilla
  fullname: Amarilla, Alberto A
  organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia
– sequence: 18
  givenname: Sarah
  surname: Wheatley
  fullname: Wheatley, Sarah
  organization: Public Health Virology Laboratory, Department of Health, Queensland Government, PO Box 594, Archerfield, Queensland, Australia
– sequence: 19
  givenname: Peter R
  surname: Moore
  fullname: Moore, Peter R
  organization: Public Health Virology Laboratory, Department of Health, Queensland Government, PO Box 594, Archerfield, Queensland, Australia
– sequence: 20
  givenname: Mitchell
  orcidid: 0000-0002-3861-1443
  surname: Finger
  fullname: Finger, Mitchell
  organization: Public Health Virology Laboratory, Department of Health, Queensland Government, PO Box 594, Archerfield, Queensland, Australia
– sequence: 21
  givenname: Nina
  surname: Kurucz
  fullname: Kurucz, Nina
  organization: Centre for Disease Control, Health Protection Division, Northern Territory Department of Health, Darwin, Northern Territory, Australia
– sequence: 22
  givenname: Naphak
  orcidid: 0000-0003-3205-4970
  surname: Modhiran
  fullname: Modhiran, Naphak
  organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia
– sequence: 23
  givenname: Paul R
  surname: Young
  fullname: Young, Paul R
  organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia
– sequence: 24
  givenname: Alexander A
  surname: Khromykh
  fullname: Khromykh, Alexander A
  organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia
– sequence: 25
  givenname: Helle
  surname: Bielefeldt-Ohmann
  fullname: Bielefeldt-Ohmann, Helle
  organization: School of Veterinary Science, University of Queensland Gatton Campus, Queensland 4343, Australia
– sequence: 26
  givenname: Andreas
  surname: Suhrbier
  fullname: Suhrbier, Andreas
  organization: Inflammation Biology Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia
– sequence: 27
  givenname: Roy A
  orcidid: 0000-0001-5778-1387
  surname: Hall
  fullname: Hall, Roy A
  email: roy.hall@uq.edu.au, j.peters2@uq.edu.au
  organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia. roy.hall@uq.edu.au j.peters2@uq.edu.au
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31826984$$D View this record in MEDLINE/PubMed
BookMark eNo1kMtKAzEYRoMo9qJvIJIXmJqkmVyWpWgVCm50Xf75k9TITGZIplXf3uJlc77dge_MyHnqkyfkhrMF50LdFYxjhlTazrsFwKc2xpyRKbdSVUpIMSGzUt4ZU2ZZq0syWXIjlDVyStoVzR77rokJ0kiHFsbQ546eQEMLx3iM-VDoERBj8oVCctRF2Ke-jBELPZSY9hTfYuczFNoHCjT5DxpT8ThWZfAYQ0T6o7kiFwHa4q__dk5eH-5f1o_V9nnztF5tK5SMj5Vx2jFuvXTaKykbUTPglgWmuNLWBGsa1nhXo6hRW854zRsNAq3RVtSAYk5uf73DoTkV2Q05dpC_dv-3xTe8wV8a
CitedBy_id crossref_primary_10_1038_s41541_022_00503_y
crossref_primary_10_1099_jgv_0_001617
crossref_primary_10_3390_biologics4010001
crossref_primary_10_3389_fimmu_2020_01817
crossref_primary_10_1016_j_virol_2021_07_004
crossref_primary_10_1038_s41467_021_23779_5
crossref_primary_10_1016_j_pathol_2022_07_001
crossref_primary_10_1002_eji_202250133
crossref_primary_10_3390_vaccines11071250
crossref_primary_10_1126_sciadv_add8095
crossref_primary_10_3390_v14040792
crossref_primary_10_3390_v14071501
crossref_primary_10_1016_j_virol_2022_07_013
crossref_primary_10_1038_s41467_021_22773_1
crossref_primary_10_1128_mSphere_00095_20
crossref_primary_10_3390_v14061298
crossref_primary_10_1016_j_onehlt_2023_100565
crossref_primary_10_1038_s41541_023_00688_w
crossref_primary_10_1016_j_bbrc_2022_05_080
crossref_primary_10_3390_insects14020166
crossref_primary_10_1128_jvi_01638_23
crossref_primary_10_3390_v12060621
crossref_primary_10_3390_pathogens9070589
crossref_primary_10_1371_journal_ppat_1009788
crossref_primary_10_1128_spectrum_02796_22
crossref_primary_10_1038_s41541_021_00328_1
crossref_primary_10_1126_sciadv_abe4507
crossref_primary_10_1371_journal_pbio_3001201
crossref_primary_10_1099_jgv_0_001991
crossref_primary_10_3390_v14051106
crossref_primary_10_1038_s41577_024_01016_6
crossref_primary_10_1099_jgv_0_001518
crossref_primary_10_3390_v14122759
crossref_primary_10_3390_vaccines9030263
crossref_primary_10_1128_mbio_01388_23
crossref_primary_10_1371_journal_ppat_1009215
crossref_primary_10_3390_v15010139
crossref_primary_10_1038_s41467_022_35407_x
crossref_primary_10_3390_vaccines9111230
crossref_primary_10_1038_s41467_022_28977_3
crossref_primary_10_1016_j_virol_2021_03_014
crossref_primary_10_3390_vaccines8030496
crossref_primary_10_3390_vaccines9101142
crossref_primary_10_1128_aem_01062_22
crossref_primary_10_3389_fmicb_2022_997058
crossref_primary_10_3390_v15051113
crossref_primary_10_3390_vaccines9030273
crossref_primary_10_3390_v13091807
crossref_primary_10_3390_vaccines8020258
crossref_primary_10_1038_s44298_024_00025_5
crossref_primary_10_3390_vaccines10010085
crossref_primary_10_1126_science_abb9425
crossref_primary_10_1128_jvi_01251_23
crossref_primary_10_3390_v13091843
crossref_primary_10_1099_jgv_0_001647
crossref_primary_10_1093_infdis_jiad238
crossref_primary_10_1016_j_pt_2023_11_002
crossref_primary_10_1016_j_coviro_2020_05_002
crossref_primary_10_3390_vaccines8030368
crossref_primary_10_1007_s00253_023_12817_5
crossref_primary_10_3390_v12091056
crossref_primary_10_3390_v13040573
crossref_primary_10_1111_pbi_14152
ContentType Journal Article
Copyright Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Copyright_xml – notice: Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
DBID NPM
DOI 10.1126/scitranslmed.aax7888
DatabaseName PubMed
DatabaseTitle PubMed
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1946-6242
ExternalDocumentID 31826984
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
0R~
4.4
53G
7~K
ABJNI
ACGFS
AENEX
AJGZS
AJWWR
ALMA_UNASSIGNED_HOLDINGS
BKF
C45
DU5
EBS
EMOBN
F5P
HZ~
NPM
O9-
OFXIZ
OVD
OVIDX
P2P
RHI
TEORI
ID FETCH-LOGICAL-c401t-8d7d019e4d7e644b250a190f0616798f98b0bed5c25c7910151b7a2c987925ac2
IngestDate Thu May 23 23:44:05 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 522
Language English
License Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c401t-8d7d019e4d7e644b250a190f0616798f98b0bed5c25c7910151b7a2c987925ac2
ORCID 0000-0003-2203-217X
0000-0002-5617-8639
0000-0002-0826-3513
0000-0002-2004-4073
0000-0001-7587-2936
0000-0003-3205-4970
0000-0003-3609-2499
0000-0001-6104-4531
0000-0002-1657-8558
0000-0002-3221-7605
0000-0003-0139-9829
0000-0001-5957-2853
0000-0002-1683-3555
0000-0003-0281-2160
0000-0002-3577-9910
0000-0002-6640-3377
0000-0001-5778-1387
0000-0002-3861-1443
0000-0002-7025-2292
PMID 31826984
ParticipantIDs pubmed_primary_31826984
PublicationCentury 2000
PublicationDate 2019-12-11
PublicationDateYYYYMMDD 2019-12-11
PublicationDate_xml – month: 12
  year: 2019
  text: 2019-12-11
  day: 11
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Science translational medicine
PublicationTitleAlternate Sci Transl Med
PublicationYear 2019
SSID ssj0068356
Score 2.5762439
Snippet Flaviviruses such as dengue, yellow fever, Zika, West Nile, and Japanese encephalitis virus present substantial global health burdens. New vaccines are being...
SourceID pubmed
SourceType Index Database
Title A recombinant platform for flavivirus vaccines and diagnostics using chimeras of a new insect-specific virus
URI https://www.ncbi.nlm.nih.gov/pubmed/31826984
Volume 11
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9tAEF2FIiEuFZS2FEq1B26RUWyvvfYxQkFRJTiB4Ib2U42UD0ScqOX38EOZ2fXWJikIellF3nhl-z2P3-zO7BByHGubqlIxQCAHByVP40hwriMGQo4lIo1zt9B-fpEPr9jPm-ym03lsRS0tKnmiHv6ZV_I_qMIxwBWzZN-B7N9B4QD8BnyhBYShfRPG_S76sxPpolmwIHSFEtRFDtqxWI6Wo_vFvLsUClfP_WbM2ofWuc2ZFz7j9tcIJ6bmPlMSVDbGp4MZjDAJEwOJum6YtooNBqHCD904TCeuLtMPZ1ibPHIRwPVqg_7TWLx7V_3QR9jMkSvNCtW13_TT9_ok-Oa8h7EJcUJ4opigTh60Zy9iV3qhtq7GW9yS5REmqTwzyXGLeplPXF639aE6pb9ZuMkTIX6jS9_-OyB2N3H4p-hKlb4g3eu9Kztwh64NssELLA9ygTNC_mufg4LN65TMOhlr7XK2yVYYYsV5cSLmcod8rL0P2vdU2iUdM_1Ets5r4PbIuE9bjKKBURQa2jCKBkZRYBRtMYo6RtHAKDqzVFBgFF1hFHXDfCZXZ4PL02FU1-OIFHjhVVRorgFCwzQ3IKMlqGcBetLCW45rebYsZE8anakkUxxkKIhJyUWiyoKXSSZU8oV8mM6mZp9Qy3jGRGGMtJYVKhW6SDHQo1eKHssz-Y189c_p9s5vunIbnuDBiz2HZLth2HeyaeEtN0cgGSv5w2H2BNXZdB0
link.rule.ids 780
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+recombinant+platform+for+flavivirus+vaccines+and+diagnostics+using+chimeras+of+a+new+insect-specific+virus&rft.jtitle=Science+translational+medicine&rft.au=Hobson-Peters%2C+Jody&rft.au=Harrison%2C+Jessica+J&rft.au=Watterson%2C+Daniel&rft.au=Hazlewood%2C+Jessamine+E&rft.date=2019-12-11&rft.eissn=1946-6242&rft.volume=11&rft.issue=522&rft_id=info:doi/10.1126%2Fscitranslmed.aax7888&rft_id=info%3Apmid%2F31826984&rft_id=info%3Apmid%2F31826984&rft.externalDocID=31826984